Trademark Overview
On Tuesday, February 24, 2026, a trademark application was filed for TILTRENZI with the United States Patent and Trademark Office. The USPTO has given the TILTRENZI trademark a serial number of 99667127. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Wednesday, June 3, 2026. This trademark is owned by Pfizer Inc.. The TILTRENZI trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceuticals, namely, anti-infectives; Medicated dermatological preparations and substances; Antifungal preparations; Smoking cessation preparations; Vaccines for human use; Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, pulmonary, respiratory, and viral diseases and disorders;; Pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, hormonal disorders, skin disorders, arthritis, asthma, cancer, cachexia, chronic obstructive pulmonary disease (COPD), eczema, hypertension, migraine, pain, stroke, obesity and diabetes;
